Saxenda® (liraglutide) injection 3 mg becomes the first FDA-approved therapy to treat obesity in adolescents in more than a decade
PR Newswire
PLAINSBORO, N.J., Dec. 4, 2020
PR Newswire
PLAINSBORO, N.J., Dec. 4, 2020
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey